Beiley Biofund EBIT per osake

Mitä Beiley Biofund tekee? Beiley Biofund Inc is a company based in Taipei City, Taiwan, with its ticker symbol 7882.TWO and ISIN TW0007882003. The company is set to go public on December 9, 2025, as indicated by its IPO date. Beiley Biofund Inc operates within the venture capital sector, focusing on investments in the biotechnology and healthcare industries. Its investment strategy emphasizes areas such as new drug and pharmaceutical research and development, advanced medical devices, pharmaceutical manufacturing and services, diagnostics, precision medicine, innovative medical service technologies, healthcare networks and platforms, and agricultural biotechnology. The company's operations are primarily domestic, targeting opportunities within Taiwan. As a venture capital firm, Beiley Biofund Inc is positioned to support early-stage and growth-stage biotechnology ventures. The firm's website is https://www.beileybiofund.com/, where further information about its investment activities and portfolio may be available. The company's sector and industry classifications are listed as N/A in the provided data, indicating that it may not fit neatly into standard industry categories or that such details have not been specified. Beiley Biofund Inc is a Taiwan-based entity, reflecting its local market focus and operational base. Beiley Biofund on yksi Eurpooliin suosituimmista yhtiöistä.